Form4insider filings, from the source

SEC Form 4 · accession 0001193805-17-000533

Assertio Therapeutics, Inc · ASRT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Mar 28, 2017
Accepted (ET)
Mar 30, 2017 · 9:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, no par valueF1,F2holding———4,038,987IBy Starboard Value and Opportunity Master Fund Ltd
Common Stock, no par valueF1,F3holding———499,512IBy Starboard Value and Opportunity S LLC
Common Stock, no par valueF1,F4holding———277,452IBy Starboard Value and Opportunity C LP
Common Stock, no par valueF1,F5holding———479,319IBy Managed Account of Starboard Value LP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock OptionF7$14.23Mar 28, 2017A29,268A—Mar 28, 2027Common Stock, no par value29,26829,268D
Forward Purchase ContractF1,F2,F6—holding————May 11, 2018Common Stock, no par value194,7301I

Explanation of responses